Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Detalles Bibliográficos
Autores principales: Satake, Hironaga, Sunakawa, Yu, Miyamoto, Yuji, Nakamura, Masato, Nakayama, Hiroshi, Shiozawa, Manabu, Makiyama, Akitaka, Kobayashi, Kazuma, Kubota, Yutaro, Mori, Misuzu, Kotaka, Masahito, Takagane, Akinori, Gotoh, Masahiro, Takeuchi, Masahiro, Fujii, Masashi, Ichikawa, Wataru, Sekikawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057450/
https://www.ncbi.nlm.nih.gov/pubmed/30042830
http://dx.doi.org/10.18632/oncotarget.25775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057450/
https://www.ncbi.nlm.nih.gov/pubmed/30042830
http://dx.doi.org/10.18632/oncotarget.25775

Ejemplares similares